A controlled, open-label post-authorisation efficacy and safety study in imlifidase desensitised kidney transplant patients with

A controlled, open-label post-authorisation efficacy and safety study in imlifidase desensitised kidney transplant patients with positive crossmatch against a deceased donor prior to imlifidase treatment, including non-comparative registry and concurrent reference cohorts

Obert

Codi protocol: 20-HMedIdeS-19
Codi EudraCT: 2021-002640-70
Grup de recerca: Nefrologia i Trasplantament Renal
Servei: Nefrologia
Investigador/a principal: Bestard Matamoros, Oriol
Malaltia: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
Fase: Fase III
Estat: Reclutant voluntaris